Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-31

FDA Approved: RAMIPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' supplemental application for ramipril (generic ACE inhibitor) under the ANDA, enabling a revised/expanded ramipril produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramipril (ramipril)

Snippet

SUPPL AP for RAMIPRIL (RAMIPRIL)